These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10773735)

  • 21. The protective antigens of equine herpesvirus type 1.
    Papp-Vid G; Derbyshire JB
    Can J Comp Med; 1978 Apr; 42(2):219-26. PubMed ID: 208736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Equid herpesvirus 1 (EHV1) infection of equine mesenchymal stem cells induces a pUL56-dependent downregulation of select cell surface markers.
    Claessen C; Favoreel H; Ma G; Osterrieder N; De Schauwer C; Piepers S; Van de Walle GR
    Vet Microbiol; 2015 Mar; 176(1-2):32-9. PubMed ID: 25582614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The equine immune response to equine herpesvirus-1: the virus and its vaccines.
    Kydd JH; Townsend HG; Hannant D
    Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vaccination against the paralytic form of EHV1?].
    Breukink HJ; Binkhorst GJ; van Oirschot JT
    Tijdschr Diergeneeskd; 1983 May; 108(9):359. PubMed ID: 6306862
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunokinetics of equine herpesvirus 1 in donkey mares: suppression of secondary cell-mediated response.
    Singh M; Charan S
    Rev Sci Tech; 1992 Sep; 11(3):901-8. PubMed ID: 1335311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA; Mock RE; Lock TF
    Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
    Stokes A; Allen GP; Pullen LA; Murray PK
    J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [EHV1, to vaccinate or not?].
    Binkhorst GJ; van Oirschot JT; Breukink HJ
    Tijdschr Diergeneeskd; 1985 Mar; 110(5):189-90. PubMed ID: 2984805
    [No Abstract]   [Full Text] [Related]  

  • 30. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model.
    Azmi M; Field HJ
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate.
    Gerdts V; Snider M; Brownlie R; Babiuk LA; Griebel PJ
    J Immunol; 2002 Feb; 168(4):1877-85. PubMed ID: 11823522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS; Wagner B; Bigbie R; Hussey SB; Rao S; Morley PS; Lunn DP
    Vaccine; 2010 Jul; 28(32):5203-11. PubMed ID: 20538091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies.
    Johnson RP; Povey RC
    J Am Vet Med Assoc; 1985 Jan; 186(2):149-52. PubMed ID: 2982774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity.
    Steinbach F; Borchers K; Ricciardi-Castagnoli P; Ludwig H; Stingl G; Elbe-Bürger A
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():3005-14. PubMed ID: 9880015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of maternally-derived antibodies on serologic responses to vaccination in kittens.
    Digangi BA; Levy JK; Griffin B; Reese MJ; Dingman PA; Tucker SJ; Dubovi EJ
    J Feline Med Surg; 2012 Feb; 14(2):118-23. PubMed ID: 22314087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection.
    Bek EJ; Hussain KM; Phuektes P; Kok CC; Gao Q; Cai F; Gao Z; McMinn PC
    Vaccine; 2011 Jun; 29(29-30):4829-38. PubMed ID: 21550375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus.
    Davies J; Hallworth JA; McLeish P; Randall S; Martin BA; Buchan A; Skinner GR
    Med Microbiol Immunol; 1994 May; 183(2):105-17. PubMed ID: 7935160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A virus-particle vaccine prepared from bovine mammillitis virus against herpes genitalis.
    Skinner GR; Buchan A; Davies J; Durham J; Castrucci G
    Comp Immunol Microbiol Infect Dis; 1991; 14(2):133-50. PubMed ID: 1657508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.